Publication | Open Access

EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation

GliomaMedicineEgfr LigandPathologyBin3 UpregulationEgfr-amplified GlioblastomaCancer BiologyHigh-grade GliomasTumor SuppressorCancer GeneticsOncologyCell BiologyTumor Biology